Hyposensitisation with AR101 in peanut allergy: proof of lesser benefit

IQWiG

17 January 2022 - In the patient-relevant outcomes, there are only disadvantages for 4- to 17-year-olds compared to a pure peanut-avoiding diet. 

Only in an artificial surrogate outcome is there an advantage.

Read IQWiG press release [German]

Michael Wonder

Posted by:

Michael Wonder